Associated Papers
Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients.
Berg A et al.
Oncotarget, 2015
25415225 (PubMed )
Supplement: oncotarget-06-1327-s002.xlsx › Sheet1
Identification of a novel transmembrane domain involved in the negative modulation of mGluR1 using a newly discovered allosteric mGluR1 antagonist, 3-cyclohexyl-5-fluoro-6-methyl-7-(2-morpholin-4-ylethoxy)-4H-chromen-4-one.
Fukuda J et al.
Neuropharmacology, 2009
Select a paper to view details